Harrow, Inc.
HROW
#5500
Rank
โ‚น119.34 B
Marketcap
โ‚น3,206
Share price
-4.38%
Change (1 day)
42.98%
Change (1 year)

Revenue for Harrow, Inc. (HROW)

Revenue in 2025 (TTM): โ‚น21.64 Billion

According to Harrow, Inc.'s latest financial reports the company's current revenue (TTM ) is โ‚น23.69 Billion. In 2024 the company made a revenue of โ‚น17.12 Billion an increase over the revenue in the year 2023 that were of โ‚น10.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Harrow, Inc. from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น21.64 B26.42%
2024 โ‚น17.12 B58%
2023 โ‚น10.83 B47.84%
2022 โ‚น7.33 B35.9%
2021 โ‚น5.39 B50.93%
2020 โ‚น3.57 B-2.04%
2019 โ‚น3.64 B26.13%
2018 โ‚น2.89 B69.22%
2017 โ‚น1.70 B26.15%
2016 โ‚น1.35 B109.88%
2015 โ‚น0.64 B513.68%
2014 โ‚น0.10 B16930.45%
2013 โ‚น0.61 M-88.72%
2012 โ‚น5.47 M
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น60.84 B 156.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.41 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA